CLINICAL_TRIALS
research
· 2025-04-04
Clinical Trial Update: tTF-NGR Randomized Study - STS [Phase 3]
Summary
Phase 3 randomized study evaluating tTF-NGR for soft tissue sarcoma is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Universität Münster | Conditions: Soft Tissue Sarcoma | Phase 3 | Status: RECRUITING